TP53INP2 and acute myeloid leukemia: Next, by analyzing datasets involving AML patients and healthy individuals from the Beat AML database, we found that TP53INP2 mRNA expression was considerably higher in AML patients, especially in AML-M4 and AML-M5 patients, than in healthy donors (Fig. 1d-e).